Sio Capital Management’s Ovid Therapeutics OVID Stock Holding History

Sio Capital Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.7M	Sell	1,005,334 -247,047	-20%	-$637K	0.45%	42
2026 Q1	$2.78M	Sell	1,252,381 -175,114	-12%	-$313K	0.4%	51
2025 Q4	$2.33M	Hold	1,427,495	–	–	0.37%	48
2025 Q3	$1.86M	Sell	1,427,495 -804,505	-36%	-$697K	0.47%	37
2025 Q2	$736K	Hold	2,232,000	–	–	0.28%	40
2025 Q1	$696K	Buy	2,232,000 +1,232,000	+123%	+$758K	0.21%	44
2024 Q4	$934K	Buy	+1,000,000	New	+$1.12M	0.26%	38
2020 Q1	–	Sell	-264,581	Closed	-$1.1M	–	83
2019 Q4	$1.1M	Buy	+264,581	New	+$835K	0.26%	58

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sio Capital Management's OVID Position: Q2 2026 in Review

Sio Capital Management reduced its Ovid Therapeutics (OVID) stake by 20% in Q2 2026, selling an estimated $637K and leaving 1,005,334 shares worth $2.7M. The position accounts for 0.45% of the portfolio, ranked #42.

Sio Capital Management first reported a position in OVID in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.78M in Q1 2026. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

Sio Capital Management held 1,005,334 shares of Ovid Therapeutics worth $2.7M as of Q2 2026.
Sio Capital Management sold 247,047 Ovid Therapeutics shares in Q2 2026, an estimated $637K.
Ovid Therapeutics made up 0.45% of Sio Capital Management's portfolio in Q2 2026, its #42 holding.
Sio Capital Management first reported a position in Ovid Therapeutics in Q4 2019 and has held it in 8 quarters since.
Sio Capital Management's Ovid Therapeutics position peaked at $2.78M in Q1 2026.
130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.